author-photo

Thomas Decker

Max F. Perutz Laboratories
University of Vienna

426

Papers

15189

Citations

Citation Trend

Filter By

Papers (426) Sort By

JournalConferenceOthers

Results from VERONICA: A randomized, phase II study of second-/third-line venetoclax (VEN) + fulvestrant (F) versus F alone in estrogen receptor (ER)-positive, HER2-negative, locally advanced, or metastatic breast cancer (LA/MBC).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)
Consensus molecular subtypes and RAS status as biomarker of treatment intensity with fluoropyrimidine, bevacizumab, and irinotecan in metastatic colorectal cancer (XELAVIRI, AIO KRK 0110).

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
[18F]-Fluorodeoxyglucose Positron Emission Tomography/CT to Assess the Early Metabolic Response in Patients with Hormone Receptor-Positive HER2-Negative Metastasized Breast Cancer Treated with Cyclin-Dependent 4/6 Kinase Inhibitors.

2021 Onkologie
Show All
- Source
- Cite
- Save
Citations (0)
Pro-atherogenic actions of signal transducer and activator of transcription 1 serine 727 phosphorylation in LDL receptor deficient mice via modulation of plaque inflammation.

2021 The FASEB Journal
Show All
- Source
- Cite
- Save
Citations (0)
Early weight loss is an independent risk factor for shorter survival and increased side effects in patients with metastatic colorectal cancer undergoing first-line treatment within the randomized Phase III trial FIRE-3 (AIO KRK-0306).

2021 International Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Awareness and Availability of Routine Germline BRCA1/2 Mutation Testing in Patients with Advanced Breast Cancer in Germany

2021 Breast Care
Show All
- Source
- Cite
- Save
Citations (0)
Triple-Negative Breast Cancer Histological Subtypes with a Favourable Prognosis

2021 Cancers
Show All
- Source
- Cite
- Save
Citations (0)
Elective Discontinuation of CDK4/6 Inhibitors in Patients with Metastatic Hormone Receptor-Positive, Her-2-Negative Breast Cancer: A Retrospective Single-Center Experience.

2021 Onkologie
Show All
- Source
- Cite
- Save
Citations (0)
Listeria monocytogenes infection rewires host metabolism with regulatory input from type I interferons.

2021 PLOS Pathogens
Show All
- Source
- Cite
- Save
Citations (0)
The CDK8 inhibitor DCA promotes a tolerogenic chemical immunophenotype in CD4+ T cells via a novel CDK8-GATA3-FOXP3 pathway

2021 bioRxiv
Show All
- Source
- Cite
- Save
Citations (0)

© Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.

沪ICP备18028330号